跳至主要内容
附件 III 条目 376 已修订 4 四月 2024

Retinol; Retinyl Acetate; Retinyl Palmitate

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate

Retinol; Retinyl Acetate; Retinyl Palmitate 列于附件 III,只能在本记录所示条件下使用。 本记录中的最大浓度:(a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE。

限用物质— 附件 III, 欧盟法规 1223/2009
最大浓度: (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
条目: 376

如何阅读本条目

Vitamin A in cosmetics became a restricted substance in 2024, with limits expressed as Retinol Equivalent, a mandatory label warning, and two different deadlines that mean different things.

  • Body lotion: 0.05% Retinol Equivalent. Other leave-on and rinse-off products: 0.3% RE.
  • The limit is a Retinol Equivalent, so retinol, retinyl acetate and retinyl palmitate are counted together, not separately.
  • The label must read: 'Contains Vitamin A. Consider your daily intake before use'.
  • 1 November 2025 stops non-compliant products being placed on the market; 1 May 2027 stops them being made available.

Regulation (EU) 2024/996 added this entry after the SCCS revisited its opinion on vitamin A. The reasoning is about total intake rather than about the product: vitamin A reaches the body from food and supplements as well as from what is applied to skin, and the limits are set with that whole picture in mind. That is also what the mandatory warning is for — it asks the reader to think about their daily intake, not about the cosmetic alone.

Two details in the wording do real work. The limits are Retinol Equivalent, which means retinol, retinyl acetate and retinyl palmitate are converted to a common basis and counted together; a formula using two of them is not entitled to the limit twice. And the two dates are not a grace period followed by a reminder. From 1 November 2025 a non-compliant product may not be placed on the Union market — that is the manufacturer or importer's first supply. From 1 May 2027 it may not be made available, which reaches stock already in a distributor's or retailer's hands.

Between those dates, a product made before the first deadline can lawfully still be sold. After the second, it cannot, wherever it sits in the chain.

核对依据

记录详情

最大浓度

(a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE

其他限制

From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 May 2027 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

警示语

For any cosmetic product containing Retinol, Retinyl Acetate or Retinyl Palmitate the following, labelling is obligatory: ‘Contains Vitamin A. Consider your daily intake before use’.

INCI 词汇表名称

Retinol; Retinyl Acetate; Retinyl Palmitate

化学名称

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate

监管信息

关键数据

CAS
11103-57-4 / 68-26-8; 127-47-9; 79-81-2
EC
234-328-2 / 200-683-7; 204-844-2; 201-228-5
附件
条目编号
376

化学身份与性质

CAS 11103-57-4 的 PubChem 二维化学结构
CAS 11103-57-4CAS 68-26-8PubChem CID 445354

Retinol

All-trans-retinol is a retinol in which all four exocyclic double bonds have E- (trans-) geometry. It has a role as a mouse metabolite, a plant metabolite and a human metabolite. It is a vitamin A and a retinol. — ChEBI

IUPAC 名称
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
分子式
C20H30O
分子量
286.5 g/mol
精确质量
286.229665576 Da
XLogP3
5.7
拓扑极性表面积
20.2 Ų
氢键供体
1
氢键受体
1
共价单元
1
已定义的立体中心
0

又称

all-trans-Retinol68-26-8Agoncaltrans-retinolVeroftalBentavit AHomagenets AoralSehkraft A
另有 16 个已报告名称
Testavol Sall-trans-Vitamin AAll-trans retinolSuper AAxerophtholumWachstumsvitaminVitaminum AVitamine ARetinoloRetinolumRetinol, all trans-(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-olRo-a-vitAntixerophthalmisches Vitamin(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-olG2SH0XKK91
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配445354

Attributed physical-property, hazard, environmental and use annotations.

  • Refractive Index: Index of refraction: 1.6410 at 20 °C/D (calculated form refractive indexes of 20-70% solutions in mineral oil); max absorption: 324-325 nm (E=1,835, 1%, 1 cm) 来源: Hazardous Substances Data Bank (HSDB)
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. If symptoms (such as redness or irritation) develop, immediately transport the victim to a hospital.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not availabl 来源: CAMEO Chemicals
  • Note: This chemical does not meet GHS hazard criteria for 0.3% (1 of 311) of reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Danger 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (15.8%): Harmful if swallowed [Warning Acute toxicity, oral]; H317 (74.9%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (75.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H360 (88.1%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H413 (74.9%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P318, P321, P330, P333+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 311 reports by companies from 14 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 311 reports by companies.; There are 13 notifications provided by 310 of 311 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Note: This chemical does not meet GHS hazard criteria for 1% (1 of 105) of reports. 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H317 (99%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (99%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H360D (99%): May damage the unborn child [Danger Reproductive toxicity] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P261, P264+P265, P272, P280, P302+P352, P305+P351+P338, P318, P321, P333+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 105 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 105 reports by companies.; There is 1 notification provided by 104 of 105 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org 来源: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: Signs and Symptoms of Overdose; Vitamin A toxicity may present with various clinical symptoms, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often include mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum retinol levels. Although the diagnosis is primarily clinical, laboratory tests such as serum retinol or retinyl ester levels can assist in confirming the diagnosis. A thorough dietary history is essential to identify excessive vitamin A intake.; Management of Overdose; Symptoms of toxicity may resolve within several weeks after discontinuing vitamin A and initiating supportive therapy. Patients with increased intracranial pressure may require lumbar punctures or medications such as mannitol and diuretics for management. Patients with hypercalcemia may need intravenous fluids and additional treatments, such as calcitonin and corticosteroids. Vitamin A toxicity can present with a range of clinical features, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often show mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum 来源: StatPearls
  • Toxicity Summary: Vision:Vitamin A (all-trans retinol) is converted in the retina to the 11-cis-isomer of retinaldehyde or 11-cis-retinal. 11-cis-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-cis-retinal, while attached to opsin in rhodopsin is isomerized to all-trans-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-trans-retinal is then released from opsin and reduced to all-trans-retinol. All-trans-retinol is isomerized to 11-cis-retinol in the dark, and then oxidized to 11-cis-retinal. 11-cis-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-cis retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitami 来源: Toxin and Toxin Target Database (T3DB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 127-47-9 的 PubChem 二维化学结构
CAS 127-47-9PubChem CID 638034

Retinol, acetate

Retinyl acetate is an acetate ester. It is functionally related to an all-trans-retinol. — ChEBI

IUPAC 名称
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate
分子式
C22H32O2
分子量
328.5 g/mol
精确质量
328.240230259 Da
XLogP3
6.3
拓扑极性表面积
26.3 Ų
氢键供体
0
氢键受体
2
共价单元
1
已定义的立体中心
0

又称

RETINYL ACETATEVitamin A acetateRetinol acetateVitamin A1 acetateall-trans-Retinol acetateCrystaletsVitamin A alcohol acetateDavitan A 650
另有 16 个已报告名称
all-trans-Vitamin A acetateRetinol, acetate, all-trans-(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetateall-trans-RetinylacetateAcetic acid, retinyl ester3LE3D9D6OYVitamin A, acetateVitamin A acetate (tritiated)O(15)-acetylretinolORISTAR RANSC-122045NSC-122760RO-1-5275CHEBI:32095VITAMIN A ACETATE 1.5 M.I.U./G((2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl) acetate
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配638034

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 0.3% (1 of 374) of reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Danger 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (83.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H360 (59.4%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H361 (39.6%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H413 (64.4%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P264, P273, P280, P302+P352, P318, P321, P332+P317, P362+P364, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 374 reports by companies from 22 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 374 reports by companies.; There are 21 notifications provided by 373 of 374 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 79-81-2 的 PubChem 二维化学结构
CAS 79-81-2PubChem CID 5280531

Retinol Palmitate

All-trans-retinyl palmitate is an all-trans-retinyl ester obtained by formal condensation of the carboxy group of palmitic (hexadecanoic acid) with the hydroxy group of all-trans-retinol. It is used in cosmetic products to treat various skin disorders such as acne, skin aging, wrinkles, dark spots, and also protect against psoriasis. It has a role as an antioxidant, a human xenobiotic metabolite and an Escherichia coli metabolite. It is a retinyl palmitate and an all-trans-retinyl ester. It is functionally related to an all-trans-retinol. — ChEBI

IUPAC 名称
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
分子式
C36H60O2
分子量
524.9 g/mol
精确质量
524.45933115 Da
XLogP3
13.6
拓扑极性表面积
26.3 Ų
氢键供体
0
氢键受体
2
共价单元
1
已定义的立体中心
0

又称

retinyl palmitateVITAMIN A PALMITATERetinol, hexadecanoateall-trans-Retinyl palmitateArovitOptovit-ARetinyl hexadecanoateVitamin A Solubilized
另有 16 个已报告名称
1D1K0N0VVCNSC-758478Retinol, palmitate, all-transAll-(e)-retinol palmitateCHEBI:17616Vitamin a palmitate (solubilized)Retinol Hexadecanoate((2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl) hexadecanoate(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl palmitatepalmitate-1-14cRetinol-15-3HRefChem:56213Retinyl-10,11-14C2CHEBI:15040201-228-5Afaxin
外部数据库标识符

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Retinol; Retinyl Acetate; Retinyl Palmitate 的清单链接

清单 Identified ingredient
参考 37479

RETINOL

CAS: 68-26-8 / 11103-57-4
EC: 200-683-7 / 234-328-2
清单 Identified ingredient
参考 37480

RETINYL ACETATE

CAS: 127-47-9
EC: 204-844-2

该记录的直接匹配结果有限,因此同时显示附件 III 中的相邻条目。

附件 III 377
相同产品类型

Alpha-Arbutin

CAS: 84380-01-8
EC: 617-561-8
附件 III 375
同一附件中的相邻记录

Kojic Acid

CAS: 501-30-4
EC: 207-922-4
附件 III 374
同一附件中的相邻记录

Daidzein

CAS: 486-66-8
EC: 207-635-4
附件 III 378
同一附件中的相邻记录

Arbutin

CAS: 497-76-7
EC: 207-850-3
附件 III 373
同一附件中的相邻记录

Genistein

CAS: 446-72-0
EC: 207-174-9
附件 III 379
同一附件中的相邻记录

Silver

CAS: 7440-22-4
EC: 231-131-3
附件 III 380
同一附件中的相邻记录

Hexyl Salicylate

CAS: 6259-76-3
EC: 228-408-6
附件 III 371
同一附件中的相邻记录

Pinene

CAS: 80-56-8 / 7785-70-8 / 127-91-3 / 18172-67-3
EC: 201-291-9 / 232-087-8 / 204-872-5 / 242-060-2

附件 III 对 Retinol; Retinyl Acetate; Retinyl Palmitate 意味着什么

Retinol; Retinyl Acetate; Retinyl Palmitate 是欧盟化妆品法规 1223/2009 附件 III 中的限用物质。其在化妆品中的使用仅限于上方条目所列的特定条件,包括适用的浓度限值、产品类型限制和必须标示的警示语。

在配方中使用该物质时,必须同时满足所有条件——最大浓度、产品范围和警示标签。满足其中一项条件并不能免除其他条件。

本记录与 3 个 CosIng 清单成分相关联,便于名称和标识符的交叉引用。 本页还显示 11 条相关附件记录,其标识符、附件逻辑或命名模式存在重叠。

合规核查清单

  • 确保配方浓度不超过:(a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
  • 确认产品类型相符:(a) Body lotion (b) other leave-on and rinse-off products
  • 在产品标签上标示所需的警示语。
  • 将使用条件记录在产品信息档案 (PIF) 中。

常见问题

Retinol; Retinyl Acetate; Retinyl Palmitate 作为限用物质列于欧盟法规 1223/2009 的附件 III。只能在条目规定的条件下使用,包括上方所示的任何最大浓度、产品类型限制和必须标示的警示语。

CAS 11103-57-4/ 68-26-8; 127-47-9; 79-81-2 是化学文摘社 (Chemical Abstracts Service) 分配给 Retinol; Retinyl Acetate; Retinyl Palmitate 的唯一数字标识符。在化妆品合规工作中,CAS 编号用于在监管数据库、原料规格书和安全评估报告之间交叉引用该物质。如果同一物质在不同条件下或不同附件中出现,多个欧盟附件条目可能共用同一 CAS 编号。

最大浓度 (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE 适用于即用型化妆品中该物质的浓度。当该物质作为混合物的一部分供应时,计算必须计入配方中所有来源的贡献。合计浓度不得超过所述限值。

使用本站的 INCI 检查器工具粘贴您的完整成分表 (INCI),并对照所有附件 II–VI 条目进行扫描。该工具会突出显示与限用、禁用或致敏原标记记录相匹配的成分。这有助于对成品配方或原料声明进行快速合规筛查。

附件 III 记录 Retinol; Retinyl Acetate; Retinyl Palmitate 的来源说明

本页概述欧盟委员会公开化妆品资料中 Retinol; Retinyl Acetate; Retinyl Palmitate 的一条附件 III 记录,并在可用时补充关联的清单或标识符匹配。

请使用本记录页面查看 Retinol; Retinyl Acetate; Retinyl Palmitate 的附件 III 条件,但任何最终监管决定都应对照现行官方附件措辞和来源文件确认。

工具与后续步骤

检查您的配方

粘贴完整的 INCI 成分表,一次性检出 Retinol; Retinyl Acetate; Retinyl Palmitate 及其他被标记的欧盟附件记录。

INCI 检查器

条目对比

将 Retinol; Retinyl Acetate; Retinyl Palmitate 与另一条附件记录并排对比,查看限制、浓度和附件归属的差异。

对比

浏览附件

查看附件 III 中的所有记录,并对比该附件中各物质的监管条件。

打开附件 III